Geode Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.45M Buy
592,865
+294,617
+99% +$4.2M ﹤0.01% 2463
2025
Q1
$3.87M Buy
298,248
+29,602
+11% +$384K ﹤0.01% 2771
2024
Q4
$3.58M Sell
268,646
-4,050
-1% -$54K ﹤0.01% 2907
2024
Q3
$1.64M Buy
272,696
+32,365
+13% +$194K ﹤0.01% 3191
2024
Q2
$791K Buy
240,331
+6,164
+3% +$20.3K ﹤0.01% 3397
2024
Q1
$878K Buy
234,167
+6,911
+3% +$25.9K ﹤0.01% 3411
2023
Q4
$996K Buy
227,256
+9,627
+4% +$42.2K ﹤0.01% 3361
2023
Q3
$908K Buy
217,629
+7,537
+4% +$31.4K ﹤0.01% 3365
2023
Q2
$733K Buy
210,092
+23,510
+13% +$82.1K ﹤0.01% 3475
2023
Q1
$718K Hold
186,582
﹤0.01% 3506
2022
Q4
$522K Sell
186,582
-389
-0.2% -$1.09K ﹤0.01% 3643
2022
Q3
$392K Hold
186,971
﹤0.01% 3856
2022
Q2
$489K Hold
186,971
﹤0.01% 3778
2022
Q1
$815K Buy
186,971
+11,118
+6% +$48.5K ﹤0.01% 3709
2021
Q4
$754K Buy
175,853
+18,737
+12% +$80.3K ﹤0.01% 3846
2021
Q3
$791K Buy
157,116
+1,835
+1% +$9.24K ﹤0.01% 3810
2021
Q2
$956K Sell
155,281
-110,264
-42% -$679K ﹤0.01% 3628
2021
Q1
$1.94M Buy
265,545
+49,506
+23% +$362K ﹤0.01% 3262
2020
Q4
$1.76M Buy
216,039
+68,212
+46% +$554K ﹤0.01% 3152
2020
Q3
$1.17M Buy
147,827
+41,815
+39% +$330K ﹤0.01% 3150
2020
Q2
$577K Buy
+106,012
New +$577K ﹤0.01% 3319